BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23590801)

  • 1. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials.
    Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Stern M; Pagnoux C; Mouthon L; Guillevin L;
    J Autoimmun; 2013 Jun; 43():60-9. PubMed ID: 23590801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
    Comarmond C; Pagnoux C; Khellaf M; Cordier JF; Hamidou M; Viallard JF; Maurier F; Jouneau S; Bienvenu B; Puéchal X; Aumaître O; Le Guenno G; Le Quellec A; Cevallos R; Fain O; Godeau B; Seror R; Dunogué B; Mahr A; Guilpain P; Cohen P; Aouba A; Mouthon L; Guillevin L;
    Arthritis Rheum; 2013 Jan; 65(1):270-81. PubMed ID: 23044708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss).
    Durel CA; Berthiller J; Caboni S; Jayne D; Ninet J; Hot A
    Arthritis Care Res (Hoboken); 2016 Mar; 68(3):374-87. PubMed ID: 26315340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
    Moosig F; Bremer JP; Hellmich B; Holle JU; Holl-Ulrich K; Laudien M; Matthis C; Metzler C; Nölle B; Richardt G; Gross WL
    Ann Rheum Dis; 2013 Jun; 72(6):1011-7. PubMed ID: 22887848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
    Pagnoux C; Quéméneur T; Ninet J; Diot E; Kyndt X; de Wazières B; Reny JL; Puéchal X; le Berruyer PY; Lidove O; Vanhille P; Godmer P; Fain O; Blockmans D; Bienvenu B; Rollot F; Aït el Ghaz-Poignant S; Mahr A; Cohen P; Mouthon L; Perrodeau E; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2015 Apr; 67(4):1117-27. PubMed ID: 25693055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss).
    Nguyen Y; Guillevin L
    Semin Respir Crit Care Med; 2018 Aug; 39(4):471-481. PubMed ID: 30404114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome).
    Mouthon L; Dunogue B; Guillevin L
    J Autoimmun; 2014; 48-49():99-103. PubMed ID: 24530234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
    Puéchal X; Pagnoux C; Baron G; Lifermann F; Geffray L; Quémeneur T; Saraux JL; Wislez M; Cottin V; Ruivard M; Limal N; Aouba A; Bonnotte B; Néel A; Agard C; Cohen P; Terrier B; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Rheumatology (Oxford); 2019 Dec; 58(12):2107-2116. PubMed ID: 31056661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
    Kim DS; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
    Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
    Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Churg-Strauss syndrome: clinical features and long-term follow-up of 16 patients].
    Lou J; Xu WB
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):524-8. PubMed ID: 19567070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C; Groh M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort.
    Gendelman S; Zeft A; Spalding SJ
    J Rheumatol; 2013 Jun; 40(6):929-35. PubMed ID: 23637321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.
    Dunogué B; Pagnoux C; Guillevin L
    Semin Respir Crit Care Med; 2011 Jun; 32(3):298-309. PubMed ID: 21674415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.